Get started
Author

Xinyuan Edward. Wu

Observed name: Xinyuan Edward Wu
ORCID: 0009-0003-2299-1159
Observed ORCID: 0009-0003-2299-1159
OpenAlex ID: A5133988457
TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD- Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al. · Cancer Discovery · 3
Table S4 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure S3 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Table S1 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure 2 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure 4 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Table S3 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure 5 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure 7 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure S1 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Supplementary DataSet 1 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Data from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure 6 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure S7 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Table S2 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure 3 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure 1 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure S4 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure S5 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure S6 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Figure S2 from TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al.
Works count: 21
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type